Use of Immunochromatographic SARS-CoV-2 Antigen Testing in Eight Long-Term Care Facilities for the Elderly
Abstract
1. Introduction
2. Materials and Methods
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- European Commission. Commission Recommendation on COVID-19 Testing Strategies, Including the Use of Rapid Antigen Tests. Available online: https://ec.europa.eu/health/sites/health/files/preparedness_response/docs/covid19_testingstrategies_recommendation_en.pdf (accessed on 28 October 2020).
- ECDC. Diagnostic Testing and Screening for SARS-CoV-2. Available online: https://www.ecdc.europa.eu/en/covid-19/latest-evidence/diagnostic-testing (accessed on 28 October 2020).
- ECDC. Increase in Fatal Cases of COVID-19 among Long-Term Care Facility Residents in the EU/EEA and the UK. Available online: https://www.ecdc.europa.eu/sites/default/files/documents/Increase-fatal-cases-of-COVID-19-among-long-term-care-facility-residents.pdf (accessed on 7 December 2020).
- Covid-19 Tracker. Available online: https://covid-19.sledilnik.org/en/stats (accessed on 15 December 2020).
- World Health Organisation. Antigen-Detection in the Diagnosis of SARS-CoV-2 Infection Using Rapid Immunoassays. Interim Guidance. 11 September 2020. Available online: https://www.who.int/publications/i/item/antigen-detection-in-the-diagnosis-of-sars-cov-2infection-using-rapid-immunoassays (accessed on 28 October 2020).
- Dinnes, J.; Deeks, J.J.; Adriano, A.; Berhane, S.; Davenport, C.; Dittrich, S.; Emperador, D.; Takwoingi, Y.; Cunningham, J.; Beese, S.; et al. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection. Cochrane Database Syst. Rev. 2020, CD013705. [Google Scholar] [CrossRef] [Scilit]
- Young, S.; Taylor, S.N.; Cammarata, C.L.; Varnado, K.G.; Roger-Dalbert, C.; Montano, A.; Griego-Fullbright, C.; Burgard, C.; Fernandez, C.; Eckert, K.; et al. Clinical evaluation of BD Veritor SARS-CoV-2 point-of-care test performance compared to PCR-based testing and versus the Sofia 2 SARS Antigen point-of-care test. J. Clin. Microbiol. 2020, 59, e02338-20. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Weitzel, T.; Legarraga, P.; Iruretagoyena, M.; Pizarro, G.; Vollrath, V.; Araos, R. Head-to-head comparison of four antigen-based rapid detection tests for the diagnosis of SARS-CoV-2 in respiratory samples. bioRxiv 2020. [Google Scholar] [CrossRef] [Scilit]
- Cerutti, F.; Burdino, E.; Milia, M.G.; Allice, T.; Gregori, G.; Bruzzone, B.; Ghisetti, V. Urgent need of rapid tests for SARS CoV-2 antigen detection: Evaluation of the SD-Biosensor antigen test for SARS-CoV-2. J. Clin. Virol. 2020, 132, 104654. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Albert, E.; Torres, I.; Bueno, F.; Huntley, D.; Molla, E.; Fernández-Fuentes, M.Á.; Martínez, M.; Poujois, S.; Forqué, L.; Valdivia, A.; et al. Field evaluation of a rapid antigen test (Panbio™ COVID-19 Ag Rapid Test Device) for COVID-19 diagnosis in primary healthcare centres. Clin. Microbiol. Infect. 2021, 27, 472.e7–472.e10. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- FIND Evaluation of SARS-CoV-2 Antigen (Ag) Detecting Tests. Available online: https://www.finddx.org/covid-19-old/sarscov2-eval-antigen (accessed on 28 October 2020).
- FIND. Comparative Evaluation of Lateral Flow Assay Tests That Directly Detect Antigens of SARS-CoV-2. Protocol Synopsis. Available online: https://www.finddx.org/covid-19-old/sarscov2-eval-antigen (accessed on 28 October 2020).
- Pray, I.W. Performance of an antigen-based test for asymptomatic and symptomatic SARS-CoV-2 testing at two university campuses—Wisconsin, September–October 2020. MMWR Morb. Mortal. Wkly. Rep. 2020, 69, 1642–1647. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Taylor, J.; Carter, R.J.; Lehnertz, N.; Kazazian, L.; Sullivan, M.; Wang, X.; Garfin, J.; Diekman, S.; Plumb, M.; Bennet, M.E.; et al. Serial Testing for SARS-CoV-2 and Virus Whole Genome Sequencing Inform Infection Risk at Two Skilled Nursing Facilities with COVID-19 Outbreaks—Minnesota, April-June 2020. MMWR Morb. Mortal. Wkly. Rep. 2020, 69, 1288–1295. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Arons, M.M.; Hatfield, K.M.; Reddy, S.C.; Kimball, A.; James, A.; Jacobs, J.R.; Taylor, J.; Spicer, K.; Bardossy, A.C.; Oakley, L.P.; et al. Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. N. Engl. J. Med. 2020, 382, 2081–2090. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Mina, M.J.; Parker, R.; Larremore, D.B. Rethinking Covid-19 Test Sensitivity—A Strategy for Containment. N. Engl. J. Med. 2020, 383, e120. [Google Scholar] [CrossRef] [Scilit] [PubMed]
| Number | NADAL COVID-19 Ag Assay vs. RT-PCR | |
|---|---|---|
| Sensitivity | 20/23 | 86.96% 95% CI: 66.41–97.23% |
| Specificity | 90/102 | 88.24% 95% CI: 80.35–93.77% |
| Area under the curve | n.a. | 88% 95% CI: 81–93% |
| Positive predictive value | 20/32 | 62.5% 95% CI: 48.91–74.37% |
| Negative predictive value | 90/93 | 96.77% 95% CI: 91.24–96.86% |
| LTCs Testing Employees | Number | Positive | Negative |
|---|---|---|---|
| Number of antigen tests in employees | 240 | 9 | 231 |
| Number of employees tested by antigen tests more than once | 38 | 1 | 72 |
| Number of RT-PCRs in employees | 155 | 16 | 139 |
| Number of employees tested by RT-PCR more than once | 17 | 1 | 34 |
| LTCs Testing Residents | Number | Positive | Negative |
|---|---|---|---|
| Number of antigen tests in residents | 373 | 26 | 347 |
| Number of residents tested by antigen tests more than once | 50 | 8 | 100 |
| Number of RT-PCRs in residents | 216 | 20 | 196 |
| Number of residents tested by RT-PCR more than once | 13 | 6 | 20 |
| Number | NADAL COVID-19 Ag Assay vs. RT-PCR | |
|---|---|---|
| Sensitivity | 9/16 | 56.25% 95% CI:29.87–80.24% |
| Specificity | 139/139 | 100.00% 95% CI: 97.38–100.00% |
| Positive predictive value | 9/9 | 100% |
| Negative predictive value | 139/146 | 95.20% 95% CI: 91.93–97.19% |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Ifko, M.; Skvarc, M. Use of Immunochromatographic SARS-CoV-2 Antigen Testing in Eight Long-Term Care Facilities for the Elderly. Healthcare 2021, 9, 868. https://doi.org/10.3390/healthcare9070868
Ifko M, Skvarc M. Use of Immunochromatographic SARS-CoV-2 Antigen Testing in Eight Long-Term Care Facilities for the Elderly. Healthcare. 2021; 9(7):868. https://doi.org/10.3390/healthcare9070868
Chicago/Turabian StyleIfko, Martina, and Miha Skvarc. 2021. "Use of Immunochromatographic SARS-CoV-2 Antigen Testing in Eight Long-Term Care Facilities for the Elderly" Healthcare 9, no. 7: 868. https://doi.org/10.3390/healthcare9070868
APA StyleIfko, M., & Skvarc, M. (2021). Use of Immunochromatographic SARS-CoV-2 Antigen Testing in Eight Long-Term Care Facilities for the Elderly. Healthcare, 9(7), 868. https://doi.org/10.3390/healthcare9070868
